Leef Brands Inc LEEF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LEEF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CAD 0.03
- Day Range
- CAD 0.03–0.03
- 52-Week Range
- CAD 0.01–0.04
- Bid/Ask
- CAD 0.03 / CAD 0.03
- Market Cap
- CAD 30.20 Mil
- Volume/Avg
- 58 / 179,226
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.92
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Leef Brands Inc is a manufacturer of cannabis-branded products manufacturer based in California. It offers products under brand names like Real Deal Resin, Ganja Gold, Heady, and Leef. Geographically, it derives a majority of its revenue from the United States. It has one operation of the Company located in Canada and the United States. The Company has one reportable business segment in the cannabis sector. It generates the majority of its revenue from the USA.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://leefbrands.com
Valuation
|
Metric
|
LEEF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.92 |
Price/Cash Flow | — |
Price/Earnings
LEEF
Financial Strength
|
Metric
|
LEEF
|
|---|---|
Quick Ratio | 0.27 |
Current Ratio | 0.50 |
Interest Coverage | −7.17 |
Quick Ratio
LEEF
Profitability
|
Metric
|
LEEF
|
|---|---|
Return on Assets (Normalized) | −6.31% |
Return on Equity (Normalized) | −823.12% |
Return on Invested Capital (Normalized) | 5.74% |
Return on Assets
LEEF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Nkcpqnsfy | Rftt | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Rrbbbctj | Zmgds | $72.9 Bil | |
HLN
| Haleon PLC ADR | Tglzpffg | Fkhbf | $37.5 Bil | |
VTRS
| Viatris Inc | Glfkwhftn | Zwnt | $13.3 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hcxpbgf | Hrnz | $11.7 Bil | |
CTLT
| Catalent Inc | Wghhvhqd | Qyplh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Mzrmfqtt | Txjx | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Bzfrsvzkc | Bhv | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qcmvtqprj | Yvpdcs | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Jxkkgcjfw | Yxbw | $3.0 Bil |